These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35718718)

  • 41. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
    Pontani D; Washton H; Bouchillon S; Johnson J
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):413-9. PubMed ID: 9758284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
    Pfaller MA; Huband MD; Streit JM; Flamm RK; Sader HS
    Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colloidal silver combating pathogenic Pseudomonas aeruginosa and MRSA in chronic rhinosinusitis.
    Feizi S; Cooksley CM; Bouras GS; Prestidge CA; Coenye T; Psaltis AJ; Wormald PJ; Vreugde S
    Colloids Surf B Biointerfaces; 2021 Jun; 202():111675. PubMed ID: 33690064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria.
    Cavassin ED; de Figueiredo LF; Otoch JP; Seckler MM; de Oliveira RA; Franco FF; Marangoni VS; Zucolotto V; Levin AS; Costa SF
    J Nanobiotechnology; 2015 Oct; 13():64. PubMed ID: 26438142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biosynthesis of Ag, Se, and ZnO nanoparticles with antimicrobial activities against resistant pathogens using waste isolate
    Shaaban M; El-Mahdy AM
    IET Nanobiotechnol; 2018 Sep; 12(6):741-747. PubMed ID: 30104447
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Crisan MC; Pandrea SL; Matros L; Mocan T; Mocan L
    Med Pharm Rep; 2024 Jul; 97(3):280-297. PubMed ID: 39234464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Watanabe A; Aoki N; Matsumoto T; Yoshida M; Sato J; Wakamura T; Sunakawa K; Kadota J; Kiyota H; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Fujiuchi S; Takahashi M; Takeuchi K; Takeda H; Ikeda H; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Morino E; Takasaki J; Mezaki K; Chonabayashi N; Tanaka C; Sugiura H; Goto H; Saraya T; Kurai D; Katono Y; Inose R; Niki Y; Takuma T; Kudo M; Ehara S; Sato Y; Tsukada H; Watabe N; Honma Y; Mikamo H; Yamagishi Y; Nakamura A; Ohashi M; Seki M; Hamaguchi S; Toyokawa M; Fujikawa Y; Mitsuno N; Ukimura A; Miyara T; Nakamura T; Mikasa K; Kasahara K; Ui K; Fukuda S; Nakamura A; Morimura M; Yamashita M; Takesue Y; Wada Y; Sugimoto K; Kusano N; Nose M; Mihara E; Kuwabara M; Doi M; Watanabe Y; Tokuyasu H; Hino S; Negayama K; Mukae H; Kawanami T; Ota T; Fujita M; Honda J; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Kaku N; Fujita J; Higa F; Tateyama M
    J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19.
    Meng Q; Li W; Jiang H; Yan H; Wang H; Ye B; Zhou L; Chen Y
    Infect Dis Ther; 2023 Feb; 12(2):563-575. PubMed ID: 36598677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predominance of methicillin-resistant Staphylococcus aureus in the residents and environments of long-term care facilities in Taiwan.
    Liu CY; Lai CC; Chiang HT; Lu MC; Wang LF; Tsai TL; Kang MY; Jan YN; Lo YT; Ko WC; Tseng SH; Lee CM; Hsueh PR;
    J Microbiol Immunol Infect; 2019 Feb; 52(1):62-74. PubMed ID: 29530709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii - A first report from the Kingdom of Saudi Arabia.
    Vijayakumar R; Sandle T; Al-Aboody MS; AlFonaisan MK; Alturaiki W; Mickymaray S; Premanathan M; Alsagaby SA
    J Infect Public Health; 2018; 11(6):812-816. PubMed ID: 29907439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1988)].
    Ikemoto H; Watanabe K; Mori T; Hayashi Y; Oguri T; Kondou T; Matsumiya H; Uedi K; Saitou A; Terai T
    Jpn J Antibiot; 1991 Jul; 44(7):770-98. PubMed ID: 1886202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa isolated in major hospitals in Nagano prefecture].
    Hachiya T; Kubo K; Yanagisawa H
    Jpn J Antibiot; 2004 Apr; 57(2):157-71. PubMed ID: 15219055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidrug-resistant organisms may be associated with bed allocation and utilization efficiency in healthcare institutions, based on national monitoring data from China (2014-2020).
    Wang XT; Meng H; Pan DF; Zheng XY; Lu WW; Chen C; Su M; Su XY; Liu Z; Ma XJ; Liang PF
    Sci Rep; 2023 Dec; 13(1):22055. PubMed ID: 38087043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2005 and 2006.
    Gomi K; Watanabe A; Aoki S; Kikuchi T; Fuse K; Nukiwa T; Kurokawa I; Fujimura S
    Int J Antimicrob Agents; 2007 May; 29(5):586-92. PubMed ID: 17387003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
    Sader HS; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
    Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
    J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Matsumoto T; Aoki N; Sato J; Wakamura T; Kiyota H; Tateda K; Hanaki H; Ohsaki Y; Fujiuchi S; Takahashi M; Akiba Y; Masunaga S; Takeuchi K; Takeda H; Miki M; Kumagai T; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Ishigaki S; Kobayasi N; Takasaki J; Mezaki K; Iwata S; Katouno Y; Inose R; Niki Y; Kawana A; Fujikura Y; Kudo M; Hirano T; Yamamoto M; Miyazawa N; Tsukada H; Aso S; Yamamoto Y; Iinuma Y; Mikamo H; Yamagishi Y; Nakamura A; Ohashi M; Kawabata A; Sugaki Y; Seki M; Hamaguchi S; Toyokawa M; Kakeya H; Fujikawa Y; Mitsuno N; Ukimura A; Miyara T; Hayasi M; Mikasa K; Kasahara K; Koizumi A; Korohasi N; Matumoto T; Yosimura Y; Katanami Y; Takesue Y; Wada Y; Sugimoto K; Yamamoto T; Kuwabara M; Doi M; Simizu S; Tokuyasu H; Hino S; Negayama K; Mukae H; Kawanami T; Yatera K; Fujita M; Kadota J; Hiramatsu K; Aoki Y; Magarifuchi H; Oho M; Morinaga Y; Suga M; Muranaka H; Fujita J; Higa F; Tateyama M
    J Infect Chemother; 2019 Sep; 25(9):657-668. PubMed ID: 31196772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China.
    Yin D; Guo Y; Li M; Wu W; Tang J; Liu Y; Chen F; Ni Y; Sun J; Zhang H; Zhao H; Hu F
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1149-1154. PubMed ID: 33411173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.